Status:
UNKNOWN
Study of Cerebral Venous System in Acute Ischemic Stroke Patients Receiving Reperfusion Therapy
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions:
Stroke
Cerebral Venous System
Eligibility:
All Genders
18+ years
Brief Summary
The VAST study is a single-center prospective observational study that enrolled individuals with acute ischemic stroke (AIS) within 24 hours onset. The patients will receive neurological examination, ...
Detailed Description
Stroke therapy had entered a new era since endovascular therapy was introduced in addition to intravenous thrombolysis. The benefit of endovascular therapy for patients with a proven proximal intracra...
Eligibility Criteria
Inclusion
- receive reperfusion therapy within 24 hours after onset;
- undergo multimodal magnetic resonance computed tomography before reperfusion therapy and CTP or magnetic resonance perfusion at 24 hours after reperfusion therapy;
Exclusion
- Contraindication to imaging with contrast agents;
- Without provision of informed consent.
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03838289
Start Date
March 1 2020
End Date
December 31 2025
Last Update
April 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The second affiliated hosipital of Zhejiang University
Hangzhou, Zhejiang, China